… or heart failure hospitalizations in patients with heart failure … of the effect of empagliflozin on
heart failure hospitalizations … -Reduced (Empagliflozin Outcomes Trial in Heart Failure and a …

… In conclusion, in patients with heart failure and a reduced ejection fraction, empagliflozin
reduced the risk of inpatient and outpatient worsening heart failure events, benefits that were …

… the effect of the drug on renal outcomes as a major outcome variable. Empagliflozin reduced
the risk of major adverse heart failure … and safety of empagliflozin on heart failure and renal …

… heart failure events in patients with heart failure and an ejection fraction >40%. Furthermore,
because patients with heart failure … than heart failure, we report on the effect of empagliflozin …

… benefit of empagliflozin on major heart failure outcomes in patients with heart failure and a
… In addition, we show that the favorable effects in this heart failure phenotype were also seen …

… This study is a separate part of the empagliflozin in heart failure patients with reduced …
the effect of empagliflozin on brain natriuretic peptide after 12 weeks of treatment and failed to …

… the estimated GFR; the latter effect was accompanied by a lower risk of serious renal
outcomes. Our findings with empagliflozin can be compared with the effects of dapagliflozin in the …

… The EMPERIAL (Effect of EMPagliflozin on ExeRcise ability … heArt faiLure) trials evaluated
the effects of empagliflozin on exercise ability and patient-reported outcomes in heart failure (…

… effects of empagliflozin in patients across the spectrum of HF and HF risk. Specifically, we
sought to (i) assess if the impact of empagliflozin … ii) determine the effect of empagliflozin on CV …

… This renal protective effect may contribute to improved heart failure outcomes as renal
impairment has been associated with worse outcomes in heart failure [35]. Moreover, potential …